Meta's stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market

ADial Pharmaceuticals stock soared after clinical trial news for their alcohol disorder treatment, and Squarespace rose after estimate-beating results.

Meta's stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market

These stocks were some of the most prominent in Tuesday trading.

After ADial Pharmaceuticals Inc., a biopharmaceutical company, issued an update about its regulatory strategy for AD04 (its lead compound for treating alcohol abuse disorder), ADIL's stock soared 22%

Airline stocks were mostly higher, as JetBlue Airways Corp. JBLU, -0.42% braced for an expected announcement from the Justice Department blocking its planned takeover of Spirit Airlines Inc. SAVE, +1.77% The DoJ is due to make an antitrust announcement at 11:30 Eastern, and JetBlue CEO Robin Hayes told the Wall Street Journal on Monday that he was expecting to be sued. The news propped up the stock of United Airlines Holdings Inc. UAL, +3.27%, Delta Air Lines Inc. DAL, +1.85% and American Airlines Group Inc. AAL, +1.61%

Cara Therapeutics Inc.'s stock CARA, -27.64% sank 31% after it posted disappointing fourth-quarter results. The biopharmaceutical company reported a loss of 56 cents per share, narrower than the same period last year of a loss of 63 cents per share, but wider than Wall Street expectations of a loss of 34 cents per share.

Dick's Sporting Goods Inc.'s stock DKS, +10.07% jumped 9% after the retailer beat analysts' earnings estimate for the fourth quarter and delivered better-than-expected full year earnings outlook.

Dish Network Corp.'s DISH, +5.46% stock rose about 7% in a bounce back from its close Monday at a 14-month low. The stock led gainers on the S&P 500.

Social media and dating app Grindr Inc. shares GRND, -6.24% sank 7%after reporting lower net income in the fourth quarter. The company's revenue rose to $54.5 million from $45 million a year earlier but net income dropped to $5.2 million compared with $6.5 million a year earlier. Executives said they expect a 25% revenue increase in fiscal 2023 from about $195 million in 2022.

Meta Platforms Inc.'s stock META, +0.46% rose slightly after a report from Bloomberg late Monday that it is poised to lay off thousands more staff members, starting later this week. Late last year, the social media giant cut 11,000 jobs in a bid to flatten its structure after a sharp drop in advertising revenue.

Shares in cloud-computing firm Nutanix Inc. NTNX, -8.83% were down 7.5%after it warned in fiscal second-quarter results that it may not be able to file its 10-Q as scheduled due to an issue with 'certain evaluation software from one of its third-party providers.' The results however beat revenue expectations of $465 million, posting a revenue increase of $486.5 million from $413.1 million in the year-ago quarter.

Elsewhere, Squarespace Inc.'s stock SQSP, +11.44% rose 14% in premarket trading after reporting fourth-quarter revenue and providing a fiscal first-quarter forecast that beat Wall Street estimates.

RV maker Thor Industries Inc.'s stock THO, -4.07% fell 3.8% after the company missed its second-quarter profit target and cut its 2023 earnings forecast to $5.50 to $6.50 a share from $7.40 to $8.70 a share previously. Wall Street analysts currently expect Thor Industries to earn $7.53 a share, according to estimates compiled by FactSet. The company's second-quarter profit was 49 cents below consensus.

Visteon Corp. stock rose 3% after the car parts maker said its board authorized a share buyback program of $300 million that will expire Dec. 31, 2026. The maker of hardware and software for cars said it expects to fund the buybacks using cash on hand and future cash flow generation.

Meanwhile, shares of WW International Inc. WW, +38.48%, also known as WeightWatchers, rose nearly 15% after the weight-management company reported fourth-quarter results and confirmed a Wall Street Journal report that it had agreed a deal to buy Sequence, which offers telehealth appointments with doctors, for $106 million in cash and stock. Crucially, the deal will give it access to obesity drugs like Ozempic, Wegovy and Mounjaro, that have become highly popular.